Hemmings HC, Mantz J.
2008.
Xenon and the pharmacology of fear.. Anesthesiology. 109(6):954-5.
Hemmings HC, Nairn AC, Greengard P.
1986.
Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Hemmings HC, Lambert DG.
2019.
The good, the bad, and the ugly: the many faces of opioids.. Br J Anaesth. 122(6):705-707.
Hemmings HC, Wlody D, Mahajan R, Webster NR.
2014.
The 2014 BJA/PGA special issue: a selection of six educational reviews.. Br J Anaesth. 113 Suppl 2:ii1-2.
Hemmings HC, Hunter JM.
2017.
Landmarks in UK anaesthesia.. Br J Anaesth. 119(6):1073-1074.
Hemmings HC, Greengard P.
2010.
Positively active: how local anesthetics work.. Anesthesiology. 113(1):250-2.
Hemmings HC, Jevtovic-Todorovic V.
2013.
Special issue on anaesthetic neurotoxicity and neuroplasticity.. Br J Anaesth. 110 Suppl 1:i1-2.
Hemmings HC, Riegelhaupt PM, Kelz MB, Solt K, Eckenhoff RG, Orser BA, Goldstein PA.
2019.
Towards a Comprehensive Understanding of Anesthetic Mechanisms of Action: A Decade of Discovery.. Trends Pharmacol Sci. 40(7):464-481.
Hemmings HC, Yan W, Westphalen RI, Ryan TA.
2005.
The general anesthetic isoflurane depresses synaptic vesicle exocytosis.. Mol Pharmacol. 67(5):1591-9.
Hemmings HC.
1998.
General anesthetic effects on protein kinase C.. Toxicol Lett. 100-101:89-95.
Hemmings HC, Shafer SL.
2020.
Further retractions of articles by Joachim Boldt.. Br J Anaesth. 125(3):409-411.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.
2005.
Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC.
2004.
Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.